Shopping Cart
- Remove All
Your shopping cart is currently empty
AKT-IN-18, an Akt inhibitor, demonstrates an IC50 value of 69.45 μM in A549 cells, effectively impeding Akt activity. It promotes apoptosis and is suitable for use in non-small cell lung cancer research [1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
| Description | AKT-IN-18, an Akt inhibitor, demonstrates an IC50 value of 69.45 μM in A549 cells, effectively impeding Akt activity. It promotes apoptosis and is suitable for use in non-small cell lung cancer research [1]. |
| Targets&IC50 | Akt:69.45 μM |
| In vitro | AKT-IN-18 (Compound 3i) exhibited cytotoxic effects on A549 cells at concentrations of 0-500 µM after 24 hours of exposure, inducing apoptosis [1]. |
| Molecular Weight | 411.86 |
| Formula | C19H14ClN5O2S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.